Clinical Scorecard: Dry Eye Dx and Tx: Tailoring the Tear Reservoir
At a Glance
| Category | Detail |
|---|---|
| Condition | Dry Eye and Ocular Surface Disease |
| Key Mechanisms | Use of scleral lenses and filling solutions to manage symptoms. |
| Target Population | Patients with dry eye and ocular surface disease. |
| Care Setting | Ophthalmology and optometry practices. |
Key Highlights
- Scleral lenses are increasingly used for managing dry eye symptoms.
- Nonpreserved saline vials are commonly used as filling solutions.
- Artificial tears and autologous serum can enhance scleral lens efficacy.
- Cyclosporine can be effectively delivered via scleral lenses.
- Tailoring filling solutions is crucial for symptom control.
Guideline-Based Recommendations
Diagnosis
- Assess ocular surface disease severity using OSDI and staining scores.
Management
- Consider scleral lenses with various filling solutions for symptom relief.
Monitoring & Follow-up
- Regularly evaluate patient symptoms and ocular surface health.
Risks
- Potential for dryness, irritation, and incomplete symptom resolution.
Patient & Prescribing Data
Patients with refractory dry eye and ocular surface disease.
Nonpreserved saline and other additives can improve patient outcomes.
Clinical Best Practices
- Use preservative-free solutions to minimize ocular surface toxicity.
- Tailor filling solutions based on individual patient needs.
- Incorporate artificial tears or autologous serum for enhanced relief.
References
- Schornack et al., 2023
- Schornack et al., 2023
- Tan et al., 2022
- Vilares Morgado et al., 2023
- Nakhla et al., 2024
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.


